NCT03043872 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 329
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 330
- group Id
- BG003
- value
- 987
- units
- Participants
- groups
- description
- During Chemotherapy: Patients received durvalumab (D) 1500 mg in combination with tremelimumab (T) 75 mg IV infusion Q3W for 4 doses/cycles (Weeks 0, 3, 6 and 9). For chemotherapy (EP), patients received etoposide (80-100 mg/m\^2) with either carboplatin (area under the curve 5-6) or cisplatin (75-80 mg/m\^2) IV infusion Q3W for 4 doses/cycles (Weeks 0, 3, 6 and 9). Post-Chemotherapy: Patients then continued to receive durvalumab 1500 mg IV infusion Q4W from Week 12 until PD, unless there was unacceptable toxicity, withdrawal of consent, or another discontinuation criterion was met. Patients also received an additional dose of tremelimumab 75 mg IV infusion post-chemotherapy (in combination with durvalumab) at Week 16 if they completed all 4 doses of durvalumab + tremelimumab during chemotherapy.
- id
- BG000
- title
- All Patients: D + T + EP
- description
- During Chemotherapy: Patients received durvalumab (D) 1500 mg IV infusion Q3W for 4 doses/cycles (Weeks 0, 3, 6 and 9). For chemotherapy (EP), patients received etoposide (80-100 mg/m\^2) with either carboplatin (area under the curve 5-6) or cisplatin (75-80 mg/m\^2) IV infusion Q3W for 4 doses/cycles (Weeks 0, 3, 6 and 9). Post-Chemotherapy: Patients then continued to receive durvalumab 1500 mg IV infusion Q4W from Week 12 until PD, unless there was unacceptable toxicity, withdrawal of consent, or another discontinuation criterion was met.
- id
- BG001
- title
- All Patients: D + EP
- description
- For chemotherapy (EP), patients received etoposide (80-100 mg/m\^2) with either carboplatin (area under the curve 5-6) or cisplatin (75-80 mg/m\^2) IV infusion Q3W for 4 doses/cycles (Weeks 0, 3, 6 and 9). An additional 2 doses of EP (at Weeks 12 and 15) could be given at the investigators' discretion if clinically indicated.
- id
- BG002
- title
- All Patients: EP
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 28
- group Id
- BG003
- value
- 62
- title
- <50
- measurements
- group Id
- BG000
- value
- 175
- group Id
- BG001
- value
- 195
- group Id
- BG002
- value
- 169
- group Id
- BG003
- value
- 539
- title
- ≥50 to <65
- measurements
- group Id
- BG000
- value
- 108
- group Id
- BG001
- value
- 98
- group Id
- BG002
- value
- 110
- group Id
- BG003
- value
- 316
- title
- ≥65 to <75
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 23
- group Id
- BG003
- value
- 70
- title
- ≥75
- denoms
- counts
- group Id
- BG000
- value
- 329
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 330
- group Id
- BG003
- value
- 987
- units
- Participants
- title
- Al Patients
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 46
- title
- <50
- measurements
- group Id
- BG000
- value
- 138
- group Id
- BG001
- value
- 157
- group Id
- BG002
- value
- 137
- group Id
- BG003
- value
- 432
- title
- ≥50 to <65
- measurements
- group Id
- BG000
- value
- 91
- group Id
- BG001
- value
- 82
- group Id
- BG002
- value
- 90
- group Id
- BG003
- value
- 263
- title
- ≥65 to <75
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 64
- title
- ≥75
- denoms
- counts
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 268
- group Id
- BG002
- value
- 269
- group Id
- BG003
- value
- 805
- units
- Participants
- title
- Global Cohort
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 16
- title
- <50
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 33
- group Id
- BG003
- value
- 112
- title
- ≥50 to <65
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 53
- title
- ≥65 to <75
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 7
- title
- ≥75
- denoms
- counts
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- units
- Participants
- title
- China Cohort
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Baseline data is presented for all patients, as well as separately for the global and China cohorts.
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 95
- group Id
- BG003
- value
- 255
- title
- Female
- measurements
- group Id
- BG000
- value
- 255
- group Id
- BG001
- value
- 242
- group Id
- BG002
- value
- 235
- group Id
- BG003
- value
- 732
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 329
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 330
- group Id
- BG003
- value
- 987
- units
- Participants
- title
- All Patients
- categories
- measurements
- group Id
- BG000
- value
- 66
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 85
- group Id
- BG003
- value
- 229
- title
- Female
- measurements
- group Id
- BG000
- value
- 202
- group Id
- BG001
- value
- 190
- group Id
- BG002
- value
- 184
- group Id
- BG003
- value
- 576
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 268
- group Id
- BG002
- value
- 269
- group Id
- BG003
- value
- 805
- units
- Participants
- title
- Global Cohort
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 27
- title
- Female
- measurements
- group Id
- BG000
- value
- 57
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 161
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- units
- Participants
- title
- China Cohort
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Baseline data is presented for all patients, as well as separately for the global and China cohorts.
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 23
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 321
- group Id
- BG001
- value
- 315
- group Id
- BG002
- value
- 322
- group Id
- BG003
- value
- 958
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 6
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 329
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 330
- group Id
- BG003
- value
- 987
- units
- Participants
- title
- All Patients
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 23
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 260
- group Id
- BG001
- value
- 255
- group Id
- BG002
- value
- 261
- group Id
- BG003
- value
- 776
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 6
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 268
- group Id
- BG002
- value
- 269
- group Id
- BG003
- value
- 805
- units
- Participants
- title
- Global Cohort
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- units
- Participants
- title
- China Cohort
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Baseline data is presented for all patients, as well as separately for the global and China cohorts.
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 215
- group Id
- BG001
- value
- 229
- group Id
- BG002
- value
- 221
- group Id
- BG003
- value
- 665
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 6
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 108
- group Id
- BG001
- value
- 96
- group Id
- BG002
- value
- 103
- group Id
- BG003
- value
- 307
- title
- Asian
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 8
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 329
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 330
- group Id
- BG003
- value
- 987
- units
- Participants
- title
- All Patients
- categories
- measurements
- group Id
- BG000
- value
- 215
- group Id
- BG001
- value
- 229
- group Id
- BG002
- value
- 221
- group Id
- BG003
- value
- 665
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 6
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 47
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 42
- group Id
- BG003
- value
- 125
- title
- Asian
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 8
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 268
- group Id
- BG002
- value
- 269
- group Id
- BG003
- value
- 805
- units
- Participants
- title
- Global Cohort
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- units
- Participants
- title
- China Cohort
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Baseline data is presented for all patients, as well as separately for the global and China cohorts.
- title
- Race
- unit Of Measure
- Participants
- population Description
- Baseline analysis was based on the global full analysis set (FAS) (all patients randomized prior to the end of global recruitment) plus the China FAS (all randomized patients in the China cohort). Patients included in both cohorts are not double-counted for the baseline analysis represented by 'All Patients'.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 329
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 330
- group Id
- BG003
- value
- 987
- units
- Participants
- groups
- description
- During Chemotherapy: Patients received durvalumab (D) 1500 mg in combination with tremelimumab (T) 75 mg IV infusion Q3W for 4 doses/cycles (Weeks 0, 3, 6 and 9). For chemotherapy (EP), patients received etoposide (80-100 mg/m\^2) with either carboplatin (area under the curve 5-6) or cisplatin (75-80 mg/m\^2) IV infusion Q3W for 4 doses/cycles (Weeks 0, 3, 6 and 9). Post-Chemotherapy: Patients then continued to receive durvalumab 1500 mg IV infusion Q4W from Week 12 until PD, unless there was unacceptable toxicity, withdrawal of consent, or another discontinuation criterion was met. Patients also received an additional dose of tremelimumab 75 mg IV infusion post-chemotherapy (in combination with durvalumab) at Week 16 if they completed all 4 doses of durvalumab + tremelimumab during chemotherapy.
- id
- BG000
- title
- All Patients: D + T + EP
- description
- During Chemotherapy: Patients received durvalumab (D) 1500 mg IV infusion Q3W for 4 doses/cycles (Weeks 0, 3, 6 and 9). For chemotherapy (EP), patients received etoposide (80-100 mg/m\^2) with either carboplatin (area under the curve 5-6) or cisplatin (75-80 mg/m\^2) IV infusion Q3W for 4 doses/cycles (Weeks 0, 3, 6 and 9). Post-Chemotherapy: Patients then continued to receive durvalumab 1500 mg IV infusion Q4W from Week 12 until PD, unless there was unacceptable toxicity, withdrawal of consent, or another discontinuation criterion was met.
- id
- BG001
- title
- All Patients: D + EP
- description
- For chemotherapy (EP), patients received etoposide (80-100 mg/m\^2) with either carboplatin (area under the curve 5-6) or cisplatin (75-80 mg/m\^2) IV infusion Q3W for 4 doses/cycles (Weeks 0, 3, 6 and 9). An additional 2 doses of EP (at Weeks 12 and 15) could be given at the investigators' discretion if clinically indicated.
- id
- BG002
- title
- All Patients: EP
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 28
- group Id
- BG003
- value
- 62
- title
- <50
- measurements
- group Id
- BG000
- value
- 175
- group Id
- BG001
- value
- 195
- group Id
- BG002
- value
- 169
- group Id
- BG003
- value
- 539
- title
- ≥50 to <65
- measurements
- group Id
- BG000
- value
- 108
- group Id
- BG001
- value
- 98
- group Id
- BG002
- value
- 110
- group Id
- BG003
- value
- 316
- title
- ≥65 to <75
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 23
- group Id
- BG003
- value
- 70
- title
- ≥75
- denoms
- counts
- group Id
- BG000
- value
- 329
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 330
- group Id
- BG003
- value
- 987
- units
- Participants
- title
- Al Patients
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 46
- title
- <50
- measurements
- group Id
- BG000
- value
- 138
- group Id
- BG001
- value
- 157
- group Id
- BG002
- value
- 137
- group Id
- BG003
- value
- 432
- title
- ≥50 to <65
- measurements
- group Id
- BG000
- value
- 91
- group Id
- BG001
- value
- 82
- group Id
- BG002
- value
- 90
- group Id
- BG003
- value
- 263
- title
- ≥65 to <75
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 64
- title
- ≥75
- denoms
- counts
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 268
- group Id
- BG002
- value
- 269
- group Id
- BG003
- value
- 805
- units
- Participants
- title
- Global Cohort
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 16
- title
- <50
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 33
- group Id
- BG003
- value
- 112
- title
- ≥50 to <65
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 53
- title
- ≥65 to <75
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 7
- title
- ≥75
- denoms
- counts
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- units
- Participants
- title
- China Cohort
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Baseline data is presented for all patients, as well as separately for the global and China cohorts.
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 95
- group Id
- BG003
- value
- 255
- title
- Female
- measurements
- group Id
- BG000
- value
- 255
- group Id
- BG001
- value
- 242
- group Id
- BG002
- value
- 235
- group Id
- BG003
- value
- 732
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 329
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 330
- group Id
- BG003
- value
- 987
- units
- Participants
- title
- All Patients
- categories
- measurements
- group Id
- BG000
- value
- 66
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 85
- group Id
- BG003
- value
- 229
- title
- Female
- measurements
- group Id
- BG000
- value
- 202
- group Id
- BG001
- value
- 190
- group Id
- BG002
- value
- 184
- group Id
- BG003
- value
- 576
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 268
- group Id
- BG002
- value
- 269
- group Id
- BG003
- value
- 805
- units
- Participants
- title
- Global Cohort
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 27
- title
- Female
- measurements
- group Id
- BG000
- value
- 57
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 161
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- units
- Participants
- title
- China Cohort
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Baseline data is presented for all patients, as well as separately for the global and China cohorts.
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 23
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 321
- group Id
- BG001
- value
- 315
- group Id
- BG002
- value
- 322
- group Id
- BG003
- value
- 958
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 6
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 329
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 330
- group Id
- BG003
- value
- 987
- units
- Participants
- title
- All Patients
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 23
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 260
- group Id
- BG001
- value
- 255
- group Id
- BG002
- value
- 261
- group Id
- BG003
- value
- 776
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 6
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 268
- group Id
- BG002
- value
- 269
- group Id
- BG003
- value
- 805
- units
- Participants
- title
- Global Cohort
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- units
- Participants
- title
- China Cohort
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Baseline data is presented for all patients, as well as separately for the global and China cohorts.
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 215
- group Id
- BG001
- value
- 229
- group Id
- BG002
- value
- 221
- group Id
- BG003
- value
- 665
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 6
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 108
- group Id
- BG001
- value
- 96
- group Id
- BG002
- value
- 103
- group Id
- BG003
- value
- 307
- title
- Asian
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 8
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 329
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 330
- group Id
- BG003
- value
- 987
- units
- Participants
- title
- All Patients
- categories
- measurements
- group Id
- BG000
- value
- 215
- group Id
- BG001
- value
- 229
- group Id
- BG002
- value
- 221
- group Id
- BG003
- value
- 665
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 6
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 47
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 42
- group Id
- BG003
- value
- 125
- title
- Asian
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 8
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 268
- group Id
- BG002
- value
- 269
- group Id
- BG003
- value
- 805
- units
- Participants
- title
- Global Cohort
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 188
- units
- Participants
- title
- China Cohort
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Baseline data is presented for all patients, as well as separately for the global and China cohorts.
- title
- Race
- unit Of Measure
- Participants
- population Description
- Baseline analysis was based on the global full analysis set (FAS) (all patients randomized prior to the end of global recruitment) plus the China FAS (all randomized patients in the China cohort). Patients included in both cohorts are not double-counted for the baseline analysis represented by 'All Patients'.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle